세계의 나노바이오테크놀러지 시장

Global Nanobiotechnology Market to Reach US$178.8 Billion by 2030

The global market for Nanobiotechnology estimated at US$119.4 Billion in the year 2024, is expected to reach US$178.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Industry End-Use, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of the analysis period. Growth in the Medical Devices End-Use segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$33.2 Billion While China is Forecast to Grow at 6.5% CAGR

The Nanobiotechnology market in the U.S. is estimated at US$33.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.6 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Nanofilms Market - Key Trends & Drivers Summarized

What Are Nanofilms and How Are They Revolutionizing Industries?

Nanofilms are ultra-thin layers of material, often just a few nanometers thick, applied to surfaces to enhance their functionality or performance. These films can be composed of different materials, including metals, ceramics, and polymers, each offering unique properties such as high conductivity, exceptional strength, and resistance to corrosion and wear. Their applications are diverse and span across industries including electronics, healthcare, energy, and automotive. In electronics, for instance, nanofilms are used to improve the efficiency and performance of devices like smartphones and TVs by enhancing screen brightness and color quality. In the healthcare sector, nanofilms contribute to the development of more efficient drug delivery systems and advanced diagnostic tools.

How Are Technological Advancements Influencing Nanofilm Developments?

Technological advancements play a pivotal role in the development of nanofilms, particularly in the methods used for their fabrication and application. Techniques such as atomic layer deposition (ALD), chemical vapor deposition (CVD), and physical vapor deposition (PVD) allow for precise control over the thickness and composition of these films, enabling tailor-made solutions for specific industry needs. Innovations in nanotechnology have also led to the creation of smart nanofilms, which can respond to environmental stimuli such as temperature, light, and pressure. These responsive films are increasingly used in sensors and wearable technology, offering adaptive properties that enhance device functionality and user interaction.

What Market Trends Are Shaping the Future of Nanofilms?

The nanofilm market is being shaped by several significant trends that are influencing both demand and supply dynamics. One of the major trends is the increasing demand for high-performance, miniaturized electronics. As devices become smaller and their functionality increases, the need for advanced materials that can perform at these reduced dimensions grows. Nanofilms meet these requirements by enabling high performance in thin layers, making them ideal for compact electronic devices. Another trend is the growing focus on sustainability, driving interest in nanofilms that contribute to energy efficiency, such as those used in solar panels and energy-efficient windows. Additionally, the automotive industry's shift towards electric vehicles has increased the need for lightweight, durable materials, where nanofilms are used to enhance battery life and vehicle performance.

What Drives the Growth of the Nanofilm Market?

The growth in the nanofilm market is driven by several factors, including the continued advancement of nanotechnology and material science, which enhances the quality and applicability of nanofilms across various industries. The booming electronics sector, with its constant demand for smaller, faster, and more efficient devices, heavily relies on nanofilm technology to meet these requirements. Additionally, the increasing utilization of nanofilms in the energy sector, particularly in solar energy applications, supports market growth as the world moves towards more renewable energy sources. Consumer behavior also influences this growth, especially as more consumers demand high-performance, durable, and energy-efficient products. Moreover, regulatory trends promoting environmental sustainability encourage the adoption of innovative materials like nanofilms to help reduce environmental impact. These factors collectively drive the dynamic expansion of the nanofilm market, reflecting its integral role in modern technological applications.

SCOPE OF STUDY:

The report analyzes the Nanobiotechnology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Pharmaceuticals & Biotechnology Industry, Medical Devices)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 79 Featured) -

• Ablynx NV
• Arrowhead Pharmaceuticals Inc.
• CaPtivate Pharmaceuticals LLC
• Celgene Corporation
• ELITechGroup
• Flamel Technologies SA
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co. Inc.
• NanoBio(R) Corporation
• Nanophase Technologies Corporation
• pSivida Corp.
• Sigma-Aldrich Corp.
• Starpharma Holdings Ltd.
• Vectura Group plc

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Nanobiotechnology - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Advances in Nanotechnology Propel Growth in Nanobiotechnology Market
  • Increasing Demand for Targeted Drug Delivery Expands Addressable Market Opportunity
  • Growth in Diagnostic and Imaging Applications Generates Demand for Nanobiotechnology Solutions
  • Technological Innovations in Nanomedicine Strengthen Business Case for Nanobiotechnology
  • Integration of Nanomaterials in Regenerative Medicine Spurs Growth in Healthcare Sector
  • Demand for Precision Medicine Expands the Market for Nanobiotechnology
  • Advances in Nano-Scale Imaging and Sensing Technologies Generate Demand for Innovative Solutions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Nanobiotechnology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Pharmaceuticals & Biotechnology Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 11: USA Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 12: USA Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: USA 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 14: Canada Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 15: Canada Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: Canada 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
• JAPAN
  • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 17: Japan Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 18: Japan Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: Japan 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
• CHINA
  • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 20: China Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 21: China Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: China 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
• EUROPE
  • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 23: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: Europe Historic Review for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: Europe 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 26: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
• FRANCE
  • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 29: France Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: France Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: France 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
• GERMANY
  • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 32: Germany Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Germany Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: Germany 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 35: Italy Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Italy Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: Italy 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 38: UK Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: UK Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: UK 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Rest of Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Rest of Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Asia-Pacific Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Asia-Pacific 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
• REST OF WORLD
  • TABLE 47: Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Rest of World Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Rest of World 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030

IV. COMPETITION